000301336 001__ 301336
000301336 005__ 20250729114241.0
000301336 0247_ $$2doi$$a10.1091/mbc.E24-12-0581
000301336 0247_ $$2pmid$$apmid:40372713
000301336 0247_ $$2ISSN$$a1059-1524
000301336 0247_ $$2ISSN$$a1044-2030
000301336 0247_ $$2ISSN$$a1939-4586
000301336 037__ $$aDKFZ-2025-01002
000301336 041__ $$aEnglish
000301336 082__ $$a570
000301336 1001_ $$0P:(DE-HGF)0$$aGürkaşlar, Hazal Kübra$$b0$$eFirst author
000301336 245__ $$aBinding of CEP152 to PLK4 stimulates kinase activity to promote centriole assembly.
000301336 260__ $$aBethesda, Md.$$bAmerican Society for Cell Biology$$c2025
000301336 3367_ $$2DRIVER$$aarticle
000301336 3367_ $$2DataCite$$aOutput Types/Journal article
000301336 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1753779767_3433
000301336 3367_ $$2BibTeX$$aARTICLE
000301336 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000301336 3367_ $$00$$2EndNote$$aJournal Article
000301336 500__ $$a#EA:D345#LA:D345# / 2025 Jul 1;36(7):br17
000301336 520__ $$aCentriole duplication is regulated by polo-like kinase 4 (PLK4) and several conserved initiator proteins. The precise timing and regulation of PLK4 activation are critical for ensuring that centriole duplication occurs only once per cell cycle. While significant progress has been made in understanding how PLK4 is activated, many aspects remain unclear. Here, we show how CEP152 contributes to the activation of PLK4. We utilize human cell lines that have been genetically engineered to rapidly degrade CEP152. Upon degradation of CEP152, localization of PLK4 at the proximal end of the centriole is disrupted. We show that binding of CEP152 N-terminal part to PLK4 increases phosphorylation and kinase activation. CEP152 controls the localization and levels of phosphorylated PLK4 at the proximal end of the centriole. CEP152 binding to PLK4 leads to phosphorylation and activation of PLK4 which might stabilize PLK4 dimer formation, thus allowing autophosphorylation. We propose that CEP152 activates PLK4 to ensure proper centriole duplication at the onset of S-phase.
000301336 536__ $$0G:(DE-HGF)POF4-314$$a314 - Immunologie und Krebs (POF4-314)$$cPOF4-314$$fPOF IV$$x0
000301336 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000301336 7001_ $$0P:(DE-He78)b97fa0c782a162d952b6197f3b916379$$aHoffmann, Ingrid$$b1$$eLast author$$udkfz
000301336 773__ $$0PERI:(DE-600)1474922-1$$a10.1091/mbc.E24-12-0581$$gp. mbc.E24-12-0581$$n7$$pbr17$$tMolecular biology of the cell$$v36$$x1059-1524$$y2025
000301336 8767_ $$810067$$92025-05-14$$d2025-07-23$$eAPC$$jZahlung erfolgt$$pE24-12-0681-RR$$v0.00
000301336 909CO $$ooai:inrepo02.dkfz.de:301336$$pVDB$$popenCost$$pOpenAPC
000301336 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000301336 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)b97fa0c782a162d952b6197f3b916379$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000301336 9131_ $$0G:(DE-HGF)POF4-314$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vImmunologie und Krebs$$x0
000301336 9141_ $$y2025
000301336 915pc $$0PC:(DE-HGF)0000$$2APC$$aAPC keys set
000301336 915pc $$0PC:(DE-HGF)0001$$2APC$$aLocal Funding
000301336 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-13
000301336 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-13
000301336 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-13
000301336 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2024-12-13
000301336 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-13
000301336 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2024-12-13
000301336 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2024-12-13
000301336 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-13
000301336 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-13
000301336 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bMOL BIOL CELL : 2022$$d2024-12-13
000301336 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2024-12-13
000301336 9202_ $$0I:(DE-He78)D345-20160331$$kD345$$lZellzykluskontrolle und Carcinogenese$$x0
000301336 9201_ $$0I:(DE-He78)D345-20160331$$kD345$$lZellzykluskontrolle und Carcinogenese$$x0
000301336 9200_ $$0I:(DE-He78)D345-20160331$$kD345$$lZellzykluskontrolle und Carcinogenese$$x0
000301336 980__ $$ajournal
000301336 980__ $$aVDB
000301336 980__ $$aI:(DE-He78)D345-20160331
000301336 980__ $$aAPC
000301336 980__ $$aUNRESTRICTED
000301336 9801_ $$aAPC